AR and prostate carcinoma: Cholestane-3β-5α-6β-triol was shown to suppress the proliferation of human prostate cancer cells such as LNCaP CDXR-3 (androgen receptor-positive) and DU-145 and PC-3 (both androgen receptor-negative) [87].